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f Abstract With the sequence of the human genome now complete, studies must
focus on how the genome is functionally organized within the confines of the cell
nucleus and the dynamic interplay between the genome and its regulatory factors to
effectively control gene expression and silencing. In this review I describe our current
state of knowledge with regard to the organization of chromosomes within the
nucleus and the positioning of active versus inactive genes. In addition, I discuss
studies on the dynamics of chromosomes and specific genetic loci within living cells
and its relationship to gene activity and the cell cycle. Furthermore, our current
understanding of the distribution and dynamics of RNA polymerase II transcription
factors is discussed in relation to chromosomal loci and other nuclear domains.
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INTRODUCTION
The completion of the human genome sequence has thus far indicated an estimate
of 30,000–75,000 genes, distributed among 3.2 billion basepairs of DNA that is
packaged into a higher-order chromatin structure [reviewed in (1–4)]. These
genes are arranged in the human interphase nucleus among the 46 chromosome
territories such that they are readily accessible to transcriptional regulators that
will mediate their expression or repression. All of this regulation takes place
within the confines of the cell nucleus having an average volume of 600–1500
m3. In addition, for cells exhibiting an open mitosis (i.e., mammalian, Dro-
sophila), this organization is disassembled and then reassembled during each cell
cycle. Determining how nuclear functions are organized and coordinated, both
spatially and temporally, is central to understanding the proper workings of the
cell and the alterations that are associated with various diseases. Recent advances
in the areas of probe development [reviewed in (5, 6)] as well as microscopy have
given us an unprecedented opportunity to visualize aspects of gene expression
and dynamics at high resolution and/or in the context of the living cell. Such
approaches that capitalize on previous biochemical and molecular advances
allow one to delve into the inner workings of the nucleus in ways that could not
have been anticipated a decade ago. In this review, I concentrate on the dynamic
organization of the genome and its associated regulatory factors within the cell
nucleus, focusing on the interplay between nuclear organization and RNA
polymerase II transcription. For a more detailed analysis of additional aspects of
nuclear structure/function the reader is directed to other reviews (7–13).
ORGANIZATION OF THE GENOME IN THE
INTERPHASE NUCLEUS
Chromosome Territories
DNA is packaged into a higher-order chromatin structure, via its associations
with histones and other nonhistone proteins, that directly impacts on gene
expression [reviewed in (11)]. Early on, studies by Rabl and Boveri suggested
that chromatin was not randomly organized within the interphase nucleus but
occupied distinct territories. Rabl suggested that chromosomes in plant cells
occupy discrete domains throughout interphase that reflect their mitotic orienta-
tion (14). Boveri confirmed these studies by showing that chromosomes main-
tained relatively fixed positions in the nuclei of Ascaris eggs (15). Furthermore,
these studies suggested that telomeres were attached to the nuclear envelope on
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one side of the nucleus and centromeres were attached on the opposite nuclear
side; this became known as a Rabl configuration. One of the most dramatic cases
for interphase chromosome organization, and how chromosomes contribute to
the assembly of a nuclear domain, comes from studies of nucleoli [reviewed in
(13)]. In a classic study reported in 1934, Barbara McClintock identified a
densely stained chromosomal region that she named the nucleolar-organizing
body or element, and that we today refer to as the nucleolar-organizing region
(NORs) (17). She went on to relate this chromosomal region to both the number
and the type of nucleoli present in mutant strains of maize. In human cells, rDNA
genes are clustered in the NORs of five pairs of acrocentric chromosomes
(chromosomes 13, 14, 15, 21, and 22). At the end of mitosis, in HeLa cells, 6 of
the 10 NORs become transcriptionally active and subsequently both the active
and inactive NORs fuse to form the nucleoli.
More recently, numerous studies have readdressed the initial questions asked
by Rabl and Boveri in a variety of systems at significantly higher resolution. In
a groundbreaking study, Cremer et al. (18) showed that laser UV microirradiation
of specific interphase nuclear areas in Chinese hamster cells damaged discrete
chromosomal regions, suggesting that the genome is organized during interphase
and provided some of the earliest insight into the concept of interphase chromo-
some territories. Early studies in Drosophila, examining polytene chromosomes
differentially stained with vital dyes in conjunction with optical sectioning
methods, have revealed these chromosomes to be closely associated with the
inner surface of the nuclear membrane and to contact the membrane at specific
sites (19–21). Furthermore, chromosomes were shown to occupy distinct terri-
tories within diploid and polytene nuclei and to spiral with the same handedness
through the nucleus (21–23). In an elegant study, Sedat and co-workers (24)
presented evidence for specific positioning of euchromatic loci within interphase
nuclei of Drosophila embryos. These investigators used fluorescence in situ
hybridization (FISH) to map the three-dimensional position of 42 DNA probes
on a single interphase chromosome (24). Fourteen of 32 probes to euchromatic
loci showed a nonrandom peripheral localization. Of six heterochromatic loci
probed, only two, the AATAC satellite and the rDNA locus, were nuclear
envelope associated, whereas four other loci were not associated with the nuclear
periphery. Further analysis of the nuclear positions of these loci showed that the
interphase nucleus in Drosophila is strongly polarized in a Rabl configuration
that, taken together with specific targeting to the nuclear envelope or to the
nuclear interior, results in each locus occupying a specific and reproducible
position within the nucleus (24). Based upon the mapping of nuclear envel-
ope contacts, it was estimated that there are on the order of 15 nuclear en-
velope interaction sites per chromosome arm, or a total of 150 nuclear envelope
association sites per diploid Drosophila nucleus. These nuclear envelope asso-
ciation sites would be spaced on average 1–2 Mb apart and could thus define
the boundaries of large loop domains tethered to the nuclear envelope in
interphase. The nuclear envelope association sites were not found to strictly
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correlate with scaffold-attachment regions, heterochromatin, or binding sites of
known chromatin proteins (24).
Although the Rabl configuration of chromosomes is generally not observed in
human cell nuclei, several groups have examined the organization of human
chromosomes in interphase nuclei with the goal of identifying other organiza-
tional principles. Using probes specific for individual human chromosomes, and
fluorescence in situ hybridization, it was shown early on that each chromosome
occupies an individual interphase domain referred to as a chromosome territory
(25–29). These territories occupy discrete and nonoverlapping nuclear regions
(30), and in mammalian cells, homologous chromosome territories are usually
not adjacent. Although repeatedly examined, the idea of a precise ordered
positioning of human chromosomes is still somewhat controversial (31–33).
However, in an extensive study, Bickmore and colleagues analyzed the nuclear
organization of every human chromosome in diploid lymphoblasts and primary
fibroblasts (34, 35). They found that most gene-rich chromosomes concentrate at
more internal nuclear regions, whereas the more gene-poor chromosomes are
located toward the nuclear periphery (Figure 1). These arrangements of chromo-
somes are established early in the cell cycle and are maintained throughout
interphase (34). However, no statistically significant relationship between phys-
ical chromosome size (base pairs) and nuclear position was found in this study.
Furthermore, chromosome subnuclear localization does not appear to be deter-
mined by the centromeres, as, remarkably, the distinctive localization observed
Figure 1 Fluorescence in situ hybridization to a human primary peripheral blood
lymphocyte showing the peripheral localization of gene-poor chromosomes 18
(green) and the more internal localization of gene-rich chromosomes 19 (red). Note the
more decondensed state of the gene-rich chromosomes. Total DNA is stained with DAPI.
Photo courtesy of Wendy Bickmore, MRC Human Genetics Unit, United Kingdom.
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is retained by regions of the chromosome arms that are translocated to chromo-
somes associated with reciprocal nuclear regions (34). Interestingly, in quiescent
or senescent cells, gene-poor human chromosome 18 was shown to move from
a location at the nuclear periphery to a more internal site in the nucleus (36).
Intriguingly, the chromosome moves back toward the nuclear periphery during a
2–4 h period of time as quiescent cells enter the G1 phase of the cell cycle. Based
upon these findings, the authors suggest that the spatial organization of the
genome is plastic, potentially leading to the ability of quiescent nuclei to be more
amenable to reprogramming (36, 37). In a parallel study, Cremer and colleagues
performed a quantitative comparison of chromosome arrangements in flat-
ellipsoid nuclei of human amniotic fluid cells and fibroblasts and in spherical B
and T lymphocytes (38). Similar to that observed in spherically shaped lympho-
cyte nuclei by the Bickmore laboratory, a preferential positioning of small
gene-dense chromosome territories was observed in the three-dimensional
nuclear interior, whereas the gene-poor small chromosomes were peripherally
localized. However, in contrast to that observed by the Bickmore group, large
chromosomes were also preferentially located toward the nuclear periphery (38).
The chicken karyotype represents an interesting example of chromosome orga-
nization. Chicken cells contain 9 pairs of gene-poor macrochromosomes and 30
pairs of gene-rich microchromosomes. Although the microchromosomes repre-
sent only 23% of the chicken genome, they contain 50% of its genes (39). In
chicken fibroblasts and neurons, the gene-rich chromosomes are concentrated in
the nuclear interior, whereas gene-poor chromosomes are located in peripheral
nuclear regions (39). Gene density–correlated radial chromosome arrangements
have been conserved during evolution of the higher-primate genome dating back
an estimated 30–40 million years (40). In the ellipsoid nuclei of amniotic fluid
cells and fibroblasts, all tested chromosome territories showed association with
the upper and/or lower part of the nuclear envelope (38). Small chromosomes
were located toward the center of the nuclear projection, whereas large chromo-
somes were located toward the nuclear periphery (38). These differences
observed on the basis of chromosome positioning may reflect the different
approaches used in sample preparation and/or may be indicative of the degree of
dynamics of chromosome territories among different cell populations.
The specific interactions that mediate the nuclear position of a particular
chromosome territory have not yet been identified. However, the nuclear enve-
lope and nuclear lamina stand out as possible candidates based on convincing
evidence that they participate in other aspects of nuclear organization [reviewed
in (41)]. Numerous pathologies have recently surfaced with regard to mutations
in protein constituents of the nuclear envelope/lamina (42). In one such disease,
X-linked Emery-Dreifuss muscular dystrophy (X-EDMD), mutations have been
identified in the emerin gene (43). Emerin is a type II integral membrane protein
localized to the inner nuclear envelope and most X-EDMD-associated mutations
result in a loss of emerin protein at the nuclear membrane [reviewed in (44)]. One
disease model has suggested the inability of emerin-null cells to sequester
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inactive chromatin at the nuclear periphery, thereby leading to altered regulation
of gene expression [reviewed in (44)]. To examine this possibility, Boyle et al.
determined chromosomal positions in lymphoblast cells from an individual with
a null mutation in emerin (35). However, the spatial positioning of chromosome
territories in such cells was not significantly different from that of their normal
counterparts. Therefore, although emerin has thus far not been implicated in
chromosomal positioning, other components of the nuclear envelope/lamina have
yet to be tested.
Aside from physical associations, changes in chromatin structure, as reflected
by protein modifications and/or associations, may also play a role in the
positioning of chromosomes. In a recent study, Almouzni and colleagues exam-
ined the long-term effects of deacetylase inhibitors on the maintenance and
nuclear compartmentalization of pericentric heterochromatin in mouse cells (45).
Incubation of cells with the histone deacetylase inhibitor, trichostatin A (TSA),
for five days selectively induced large-scale movements of centromeric and
pericentric heterochromatin to the nuclear periphery without any significant
effect on either its methylation status or telomere position. In addition, these
regions lost their association with heterochromatin 1 (HP1) proteins, which
became distributed throughout the nucleoplasm (45). Interestingly, upon drug
removal (20 h) these chromatin regions resumed their typical nuclear positions
and their association with HP1. Based upon the necessary lengthy incubation
with TSA, prior to observing the effects, the authors posit that several cell
divisions may be required to destabilize the HP1 population. As each round of
DNA replication would dilute by half the parental nonacetylated histones with
newly incorporated acetylated histones, eventually a complete loss of HP1 would
be achieved (45). The observed reversibility of the TSA effect in mammalian
cells was not found to be the case in Schizosaccharomyces pombe, where TSA
treatment resulted in a delocalization of the HP1 homologue and severe defects
in centromeric regions and chromosome segregation during mitosis (46, 47).
Almouzni and colleagues suggest that this difference may relate to a lack of
methylation of pericentric DNA in S. pombe, as DNA methylation has been
shown to induce histone deacetylation in mammalian cells and could thus result
in the observed recovery after TSA removal (45).
In addition to pursuing the associations that mediate chromosome territory
position, several groups have assessed the parameters involved in the organiza-
tion of individual chromosome territories. Upon increasing concentrations of salt,
up to 1.8 M, gene-poor chromosome 18 was released from the nuclear remnants,
whereas gene-rich chromosome 19 remained in the center of the nuclei, suggest-
ing a differential association with the nuclear substructure based upon gene
density (34). Furthermore, gene-rich chromosome 19 assumed a more compact
structure in the absence of transcription, although its overall position in the
nucleus was not altered (34). In a separate study, Berezney and colleagues found
chromosome territory organization to be maintained despite the extraction of
greater than 90% of the histones and other soluble nuclear proteins in DNA-rich
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nuclear matrix preparations. Interestingly, upon complete extraction of internal
nuclear matrix components with RNase treatment followed by 2 M NaCl, a
disruption of higher-order chromosome territory architecture was achieved,
suggesting a role for RNA/RNP in chromosome organization (48). In conjunction
with the observed chromosome disruption, a small set of 40–90-kD acidic
proteins, distinct from the major nuclear matrix proteins, was released (48).
These proteins are being pursued as potential mediators of chromosome territory
organization. Based upon the effect of RNase treatment, it is tempting to
speculate that stable nuclear RNAs and/or RNPs may play a role in the
maintenance of interphase chromosome organization. Interestingly, Almouzni
and colleagues have recently identified the involvement of RNA in mediating the
interaction of heterochromatin protein 1 (HP1) and methylation of H3 lysine-9
with pericentric heterochromatin (49).
Positioning of Active Versus Inactive Genes Within
Chromosome Territories
An extensive effort has focused on examining the position of individual genes
and/or chromosomal regions within chromosome territories to assess the rela-
tionship of gene activity to chromosomal position. Several studies have sug-
gested that inactive genes may be located in interior regions of chromosomal
territories and active genes may concentrate along the periphery (30, 50–52),
adjacent to nonchromosomal nucleoplasmic space, termed the interchromosome
domain compartment (ICD) (53, 54). However, other studies indicate that this
type of organization may not be a general trend (55, 56). In addition, an overall
analysis of gene-rich (GC-rich) chromosomal regions indicates that they are
distributed throughout chromosomal territories with no preference for their
periphery (57). Interestingly, the gene-rich major histocompatibility complex
(MHC), at human chromosome 6p21.3, was localized external to the chromo-
some 6 territory or to large chromosomal loops that extend from the surface of
the bulk chromosome 6 territory (52). Transcriptional upregulation of the MHC
class II genes by interferon-gamma resulted in an increase in the frequency with
which this gene cluster appeared on external chromosomal loops (52). A similar
organization was observed for the human epidermal differentiation complex at
1q21, which contains genes that are involved in keratinocyte differentiation (58).
This region appears to extend outside of the chromosome 1 territory in keratin-
ocytes where the genes are highly expressed, but not in lymphoblasts where they
are silent (58). The amplified and highly expressed ERBB2 genes have also been
observed to extend from the chromosome 17 territories in a breast cancer cell line
(59). While the position of a number of active genes have been mapped with
respect to their corresponding chromosome territories (50, 51, 60), the most
extensive analysis has been done on a 1-Mb region of human chromosome
11p13 and the syntenic region in the mouse (61). This region of chromosome 11
contains ubiquitously expressed genes as well as genes whose expression is
tissue type specific (62–64). In addition, large intergenic stretches of DNA are
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present within this region (62, 63). All the 11p13 loci studied, including
expressed genes, were located within the chromosome territory, compared with
a locus from 11p15 that localized to the territory edge (61). Similar observations
were made with its region of conserved synteny in the mouse. Furthermore,
tissue-restricted genes were not relocated to the periphery of the respective
chromosome territory in expressing cells (61). Based upon these findings, it was
concluded that gross remodeling of chromosome territories does not occur to
accommodate relatively small changes in gene expression in mammalian cells
(61). Instead, local changes in chromatin fiber conformation are likely to be
associated with gene expression (65, 66). The respective factors involved in this
process are likely to have accessibility to neighborhoods throughout the chro-
mosome territory, with local changes in protein modification and chromatin
structure regulating the binding affinities and subsequent gene expression profiles.
CHROMOSOME DYNAMICS
Although individual chromosome territories have been localized in fixed cells to
discrete nuclear regions, several early studies provided initial evidence to support
the concept that these territories are dynamic in the interphase nucleus and that
their positions may be cell cycle dependent. Using a composite probe to
chromosome 8, Ferguson & Ward showed by in situ hybridization that in G1
cells chromosome 8 centromeres localized adjacent to the nuclear periphery and
the chromosomal arms extended toward the nuclear interior (67). However, in
G2 cells the chromosome reoriented itself; the centromeres were internal, and the
chromosomal arms extended toward the nuclear periphery. A similar redistribu-
tion was observed in brain tumor cells where centromeres were dispersed during
G1 and S-phase and became clustered toward the nuclear interior during G2 (68).
Examination of chromosome positioning in CNS nuclei in larval Drosophila
indicated large chromosomal movements in diploid interphase nuclei (69). At the
onset of S-phase, an increased separation was seen between proximal and distal
positions of a long chromosome arm (69). However, a study of centromeres in
living human cells using a CENP-B-GFP fusion protein found that centromeres
in HeLa cells were predominantly stationary, although movement of individual
or small groups of centromeres was occasionally observed at very slow rates of
7–10 m/h (70). Therefore, different paradigms are likely to exist for chromo-
some movement in different cell types within an organism, as well as in similar
cell types among different organisms, depending upon the overall chromatin
organization within the respective cell type. One of the most provocative studies
demonstrating a correlation between chromosome position and cell physiology
comes from work on human epileptic foci (27). In normal male cortical neurons,
the X chromosome was localized to the nuclear periphery. However, when cells
in an electrophysiologically defined seizure focus were observed, there was a
dramatic increase from 7% to 45% in the number of cells exhibiting internal
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nuclear localization of the X chromosome (27). A similar observation was
previously reported in neurons after 8 h of electrical stimulation (71). However,
more recent live cell studies in tissue culture cells, examining the dynamics of
fluorescently labeled chromosomes, have concluded that interphase chromosome
territories in general undergo only a limited large-scale translational motion
(72–75).
Dynamics of Chromosomal Regions and Genetic Loci in
Living Cells
In a significant breakthrough, Belmont and coworkers developed an approach,
based upon the use of the lac operator/repressor system, to directly visualize
chromatin organization and dynamics in living cells (76). By introducing a lac
operator array into Chinese hamster ovary cells with the dihydrofolate reductase
gene and amplifying it through methotrexate selection (76), a stable cell line was
selected containing a 90-Mbp chromosomal array that can be visualized using
a GFP-lac repressor fusion protein. The array formed a late-replicating homo-
geneously staining region (HSR) (77). Cell cycle analysis indicated that the
integration site was peripherally localized throughout most of interphase. How-
ever, during several hours in mid- to late S-phase, the HSR decondensed and
moved toward the nuclear interior correlated with its DNA replication (77).
Using this system the Belmont group has been able to directly visualize activator
binding in living cells, and they have found that chromatin decondensation
occurs upon activator binding and in the absence of transcription (78). However,
studies using a tandem array (2 Mbp) of the mouse mammary tumor virus
(MMTV) promoter driving a ras reporter have shown that this array does require
transcription for chromatin decondensation (79). Therefore, different loci may
respond to different signals for chromatin decondensation. In a separate study,
using a cell line with a smaller integration (150–300 Kbp), VP16 targeting to the
locus was also shown to induce its movement from the nuclear periphery to a
more internal nuclear region (80), suggesting that internal nuclear regions may be
more amenable to potentially active loci. Furthermore, the recruitment of several
histone acetyltransferases, including GCN5, P/CAF, and p300/CBP, and hyper-
acetylation of all core histones was observed (78). Examination of the extended
chromosome fibers by light and electron microscopy supports the existence of a
folded chromonema model based upon 100-nm chromonema fibers formed by
compaction of 10-nm and 30-nm chromatin fibers (76, 78).
The lac operator/repressor system has provided an unprecedented approach to
visualizing chromatin organization and remodeling in real time. An elaboration
of this approach has allowed for the development of a cell system that offers
direct read-out of gene expression in living cells. Using the lac operator/repressor
system and two color variants of GFP, Spector and colleagues have developed a
system to visualize a genetic locus and its protein product directly in living cells
(66). Dynamic morphological changes in chromatin structure, from a condensed
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to an open structure, were observed during gene activation, and targeting of a
cyan fluorescent protein reporter to the peroxisomes was directly visualized in
living cells (Figure 2) (66).
In order to monitor the movements of individual genetic loci on different
human chromosomes, Bickmore and co-workers randomly integrated a lac
operator array into the human genome and selected clones that contained a single
integration site of the array (128-mer array) at different chromosomal positions
(81). In general, chromatin associated with the nucleolus or nuclear periphery
was more restricted in its movement than chromatin associated with other
nucleoplasmic regions, indicating that these structures may act as anchoring sites
(81). For example, 13q22, a region associated with the nuclear periphery,
exhibited a maximum range of movement of 0.9 m, whereas 5p14, a nucleo-
plasmic locus, exhibited a maximum movement of 1.5 m. Interestingly, the
5p14 and 3q26.2 loci exhibited similar diffusion coefficients (1.25 X 104
m2/s), although their gene density and replication timing were determined to be
different. The 5p14 locus resides in a G band (gene poor, late replicating),
whereas 3q26.2 is in an R band (gene dense, early replicating). The diffusion
coefficient for human loci (81) was estimated to be fourfold lower than that
estimated for budding yeast centromeres, which move considerably less than
coding regions (82, 83). This constrained motion may relate to associations with
nuclear structures, with the relative concentration of DNA relative to the nuclear
volume, and/or the significantly larger amount of heterochromatin present in
human cells that may act as anchoring sites.
Several studies examining chromatin dynamics in Drosophila have also
identified constrained chromatin movements. An earlier study in Drosophila
Figure 2 Localization of a stably integrated regulatable genetic locus in the “off”
(A) and “on” (B) states using the lac operator/repressor system (66). In the “off”
position the locus is visualized via CFP-lac repressor protein as a single dot in each
interphase nucleus (A). Upon transcriptional activation the locus decondenses and the
protein product of the transcription unit is localized to cytoplasmic peroxisomes (B).
The protein product is visualized via a CFP-peroxisome targeting signal fusion
protein.
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embryos, examining a topoisomerase II-enriched 359-base pair repeat block of
heterochromatin on the X chromosome (82), revealed that this region of chro-
matin undergoes significant diffusive Brownian motion with a diffusion constant
of 2.0 X  107 m2/s within a restricted radius of 0.9 m (82). Interestingly,
this chromatin region is a scaffold-associated region (SAR) in Drosophila. More
recently, a study to track chromosome motion in Drosophila spermatocytes (73)
using a lac operator array revealed multiple levels of constrained motion. Over
short time intervals of a few seconds, chromatin movement was restricted to
submicron-sized regions (0.3 m/s) of the nucleus. Over time periods of an hour
or more, loci were found to be considerably more mobile, with a range of several
microns. Interestingly, this long-range motion was restricted to early G2 sper-
matocytes and was not observed later in G2, as cells approached meiotic
prophase. The overall chromatin movements were consistent with a random walk
as no directed movements were observed (73). The average diffusion coefficient
of single sites in early nuclei was 1.0 X 103 m2/s, about one order of
magnitude greater than that observed for a centromeric domain in yeast (82).
Although specific chromosomal regions demonstrate various levels of confined
movement, the overall position of chromosomes was constrained to specific
nuclear territories.
A similar approach to examine chromatin dynamics in Saccharomyces cer-
evisiae evaluated specific chromosomal sites that were tagged with a lac operator
array at the LEU2 locus near the centromere of chromosome III (82). Using
single particle tracking methods, the chromatin was found to undergo diffusive
Brownian motion with a diffusion constant of 5.0 X 108 m2/s within a
restricted radius of less than 0.3 m, a region that corresponds to 1% of the
nuclear volume (82). Interestingly, cells treated with a microtubule depolymer-
izing drug, nocodazole, resulted in less-confined chromatin diffusion (82).
However, the motion of noncentromeric sites was not affected by such drugs
(83). In a more recent study, examining G1 nuclei in S. cerevisiae, early and late
origins of replication exhibited large rapid movements (0.5 m in 10 s) that
surprisingly were ATP dependent, whereas smaller saltatory movements (0.2
m), similar in range to those observed in Drosophila (73), were observed
throughout interphase (83). Given that the yeast nucleus measures 2.0 m in
diameter, these 0.5 m movements are extremely significant and demonstrate
that chromosomal regions can move within large nuclear areas over short time
periods. The large movements were proposed to reflect the action of ATP-
dependent enzymes involved in transcription and chromatin remodeling (83).
These rapid movements became constrained in S-phase, and they dropped
fourfold in G1 cells, as cell density increased to2 X 107 cells/ml, or just before
the diauxic shift from fermentative to oxidative metabolism (83). However,
telomeres and centromeres were found to provide replication-independent con-
straint on chromatin movement in both G1 and S-phase cells, supporting the
concept that periodic sites along a chromosome may tether it and thereby confine
its position within a restricted nuclear region (83). The large rapid movements
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observed for regions of yeast chromosomes have been suggested to indicate that
chromosome territories are loosely arranged. Given that yeast contain little
heterochromatin, their chromosomes may contain fewer anchoring sites. The
dynamics of chromatin in vivo may in part reflect nuclear volume: DNA length,
as reduction in chromatin movement correlates with reduced nuclear volume in
several instances (73, 81, 83).
An alternative live cell approach, which allows the visualization of individual
or a few different chromatid territories in living cells, has made use of micro-
injection of the fluorescent thymidine analog Cy3-AP3-dUTP into the nuclei of
cultured human cells (84). The analog incorporates into replicating DNA in
S-phase, and after growth for several cell cycles random segregation of labeled
and unlabeled chromatids into daughter nuclei results in nuclei exhibiting
individual labeled chromatid territories that can be studied in living cells.
However, as compared to the use of the lac operator/repressor system described
above, the chromatid(s) that is labeled is randomly selected and not stable. Such
studies have indicated that chromatid territories are composed of subcompart-
ments with diameters ranging between 400–800 nm, referred to as subchromo-
somal foci. The foci are composed of either early or late-replicating chromatin;
similar size replication foci have been reported previously during S-phase (85).
Time-lapse imaging has indicated changes in the shape and positioning of
individual chromatid territories, repositioning of subchromosomal foci within
stable territories, and changes in patterns of folding and extension of the foci over
time (84).
DISTRIBUTION OF RNA POLYMERASE II
TRANSCRIPTION SITES
Several approaches have been used to examine the organization of transcription
sites within the nuclei of mammalian cells. In a series of now classic studies,
Fakan and colleagues used 3H-uridine incorporation, after short pulses, combined
with electron microscopic autoradiography and observed non-nucleolar tran-
scription sites to be distributed throughout the nucleoplasm of mammalian cells
with a preference for the borders of condensed chromatin (86–88). In addition,
transcription sites are also observed on the periphery of interchromatin granule
clusters and at other nucleoplasmic regions (89, 90). Transcription sites are
specifically associated with nuclear structures termed perichromatin fibrils,
which are thought to represent nascent transcripts based upon the pulse labeling
experiments as well as antibody labeling for transcription and pre-mRNA
processing factors [reviewed in (7, 91)]. Perichromatin fibrils are RNase sensitive
and their appearance is inhibited by pretreatment with actinomycin D or -aman-
itin [reviewed in (92)]. More recent studies have used Br-UTP incorporation (93,
94) to examine the localization of transcription sites both at the immunofluores-
cence and electron microscopic levels (Figure 3). Using this approach, Pombo et
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al. (95) identified 10,000 non-nucleolar transcription sites in HeLa cell nuclei.
Of these 8000 are thought to represent RNA pol II transcription sites and
2000 represent RNA pol III transcription sites. Each of these sites measures
50 nm in diameter and has been termed a transcription factory (96), as the
authors propose a model in which RNA polymerases are associated with the
nuclear skeleton–forming factories, and templates surround the factories. Tran-
scripts are extruded from the factories upon passage of templates through the
positionally fixed polymerases (97).
Numerous studies have indicated that active genes as well as many transcrip-
tion factors are associated with the nuclear matrix or nucleoskeleton [reviewed in
(98–102)]. Most interestingly, the nuclear lamins, an indisputable structural
Figure 3 Human bladder carcinoma T24 cells were microinjected with Br-UTP and
incubated for 12 min to label transcription sites. Double-labeling with mouse anti-BrdU
antibody (6-nm colloidal gold particles) and chicken anti-RNA polymerase II antibody
(15-nm colloidal gold particles) shows that both localize at perichromatin fibrils (arrow-
heads). Bar equals 100 nm. Photo courtesy of D. Cmarko & S. Fakan, University of
Lausanne, Switzerland.
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element of the nuclear periphery as well as internal nuclear regions [reviewed in
(41)], have recently been shown to be necessary for RNA polymerase II
transcription both in mammalian cells as well as in nuclei from Xenopus laevis
(103). When lamins were disrupted in BHK cells or in nuclei from early Xenopus
gastrulae by addition of a N-terminal human lamin A (NLA), a dominant-
negative lamin mutant, the lamins formed abnormal nucleoplasmic aggregates
(103). Br-UTP incorporation was dramatically decreased in these nuclei and
TATA binding protein (TBP) was found in the nucleoplasmic aggregates.
However, the distribution of Sp1, a RNA pol II gene-specific transcription factor,
was not affected by addition of the NLA nor was RNA pol I or pol III
transcription. Based upon these data, the authors proposed that RNA pol II
transcription and the distribution of TBP depend upon the maintenance of normal
nuclear lamin organization (103).
ORGANIZATION OF TRANSCRIPTION SITES WITHIN
CHROMOSOME TERRITORIES
To examine the overall relationship of transcription to the organization of
chromosomal territories, Verschure et al. (56) combined chromosome painting,
to identify a specific territory, with Br-UTP incorporation, to identify transcrip-
tion sites. Confocal image stacks of hybridized chromosome paint probes
indicated that chromosome territories are not compact structures, as had been
previously implied; instead they appeared as open structures consisting of
clusters of 300–450-nm domains that were sometimes interconnected, forming a
thread-like, folded structure (56). The subdomains were surrounded by less
intensely labeled areas. When such analysis was combined with Br-UTP labeling
to localize nascent RNA, transcription sites were observed to extend throughout
the territories of gene-rich chromosome 19 and the active X chromosome (Figure
4). Interestingly, newly synthesized RNA localized in those regions that labeled
less intensely with the chromosome paint probes. Based upon these data, the
authors propose that the interchromosomal domain space (53, 54, 104) extends to
regions within chromosome territories (56). A similar localization of transcrip-
tion sites throughout chromosome territories in rapidly dividing wheat cell nuclei
has been observed (55).
TRANSCRIPTION FACTOR LOCALIZATION
Dynamic Interactions with the Genome
Although many models of transcription based upon in vitro experiments impli-
cate stable complexes that are bound to chromatin for relatively long periods of
time [reviewed in (105)], recent data from live cell experiments indicate just the
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contrary—highly dynamic interactions of factors with the chromatin substrate
[reviewed in (106)]. Live cell imaging using GFP fused to several different
transcription factors (107–109), as well as to histone H1 and the HMG 17, 14
proteins [reviewed in (12)], in combination with fluorescence recovery after
photobleaching (FRAP) techniques, has shown that these nuclear proteins are
highly dynamic, exhibiting rapid exchange rates, with occupancy times of
minutes to a few seconds at their target substrates. In contrast, such studies have
indicated that the core histones remain immobilized on chromatin for hours
(110). In a groundbreaking study, the Hager group demonstrated that the
glucocorticoid receptor undergoes rapid exchange, with a t1/2 of 5 s, between
chromatin regulatory elements and the nucleoplasm in the presence of ligand
(107). These data support a “hit-and-run” model of factor association with the
response element, and ATP-dependent chromatin remodeling activities have
been suggested to be involved in this rapid exchange of proteins (111). Mancini
and colleagues found the unliganded estrogen receptor exhibited a rapid
exchange, t1/2 1 s, whereas agonist or partial agonist slowed recovery (t1/2 5–6
Figure 4 Confocal optical sections showing the distribution of transcription sites in
relation to the two X-chromosome territories in human female primary fibroblasts. Nascent
RNA was labeled by incorporation of Br-UTP (green) and the X-chromosome territories
were labeled by FISH (red). Transcription sites occur as defined spots throughout one of the
two X-chromosome territories (most likely the active X, panels A, B), whereas almost no
transcription sites are observed in the other X-chromosome territory (most likely the
inactive X, panels A, D). An additional example of an active X territory (panel C) and
inactive X territory (panel E) from a different nucleus are also shown. Chromosome
territories have a distinct substructure, showing strongly labeled structures that are sur-
rounded by less intensely labeled structures. The intensely labeled structures have a
diameter in the range of 300–450 nm. Nascent RNA preferentially accumulates between
the intensely labeled structures, in the areas with little to no DNA FISH labeling.
Reproduced from Verschure et al. The Journal of Cell Biology, 1999, 147:13–24, by
copyright permission of The Rockefeller University Press.
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s) (108, 113). Interestingly, the dynamics of the unliganded estrogen receptor was
shown to be ATP and proteasome dependent (108). A similar degree of rapid
dynamics has been observed between a receptor coactivator, SRC-1, or a general
coregulator (CBP), and an estrogen-receptor-lac repressor fusion protein bound
to a lac operator array (113). Furthermore, the identification of members of a
chaperone complex at certain promoters has resulted in a model whereby
molecular chaperones may be essential for promoting continuous disassembly of
transcriptional regulatory complexes, resulting in the observed turnover and the
ability to respond to signaling changes (114). For example, the p23 molecular
chaperone can disrupt thyroid hormone receptor DNA complexes in vitro and
appears to compete with a coactivator for association with the thyroid receptor
ligand binding domain, resulting in opposing effects on the stability of the
receptor-DNA interaction (115). Intriguingly, regardless of this rapid dynamics
of factors, protein complexes can be visualized at specific promoters and within
an increasing number of different nuclear organelles. The basis for maintaining
the highly local concentrations of these factors such that steady-state levels form
functional complexes and are easily observed in intact cells remains to be
elucidated.
Nuclear Domains and Transcription Factor Localization
The localization of the large subunit of RNA pol II as well as a number of general
transcription factors (GTFs) and promoter-specific transcription factors have
been examined by immunofluorescence microscopy. Although, as expected,
these factors localize at transcription sites that are distributed throughout the
nucleoplasm in a fine punctate localization as described above, many of them
have also been found concentrated in a number of different nuclear domains in
which transcription has thus far not been reproducibly detected, except in the
case of the OPT domain (116) (Figure 5). As compared to the localization of
RNA pol II LS, the distribution of GTFs is somewhat more variable. Grande et
al. (117) examined the localization of a number of GTFs including TFIIH (p62)
and TFIIF (RAP74) and BRG1, a human homologue of the yeast SWI/SNF
chromatin remodeling complex. All of these proteins are distributed in a fine
punctate distribution throughout the nucleoplasm. Other promoter-specific tran-
scription factors such as E2F-1 (117), GATA-1 (118), Oct1 (116), Pit-1 (119),
Sp1 (103), Sp100 (120), CBF/AML-related factors (121), and the glucocorti-
coid receptor (107) have also been localized throughout the nucleoplasm in a
punctate distribution. Surprisingly, except for TFIIH, little correlation was
observed between the localization of other GTFs and the localization of RNA pol
II LS and transcription sites (117). In addition to this broad distribution, many
transcription-related proteins also localize to other nuclear domains, such as
nuclear speckles, the OPT domain (116), Cajal bodies (122, 123), promyelocytic
leukemia (PML) nuclear bodies [reviewed in (9, 124)], and heat shock factor 1
(HSF1) granules (125, 126), as is discussed below.
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THE SPECKLE CONNECTION The unphosphorylated or the serine-5 phosphory-
lated form of the large subunit of RNA pol II (RNA pol II LS) that is involved
in transcriptional initiation is localized in a diffuse nuclear distribution that has
considerable, but not complete, overlap with sites of transcription (Figure 3)
(117, 127). The serine-2 phosphorylated form of RNA pol II LS, which is
involved in elongation, is localized similarly, but in addition it is localized to
nuclear speckles (Figure 5) when observed by immunofluorescence microscopy
(127, 128). However, some studies have not observed an enrichment of RNA pol
II LS in speckles [for example (117)]. These nuclear regions correspond to
interchromatin granule clusters (IGCs), 0.5–1.0 m nuclear regions composed of
granules each measuring 20–25 nm in diameter. IGCs have been implicated in
the modification and/or assembly of premRNA splicing factors and possibly a
subset of transcription factors (129–131). As transcription does not occur in
IGCs and because this localization pattern of RNA pol II LS is primarily
observed by labeling with one antibody, H5 (127), it has been suggested that this
epitope may be present both on the elongating form of RNA pol II as well as on
a form that is stored and/or in the process of being modified in IGCs prior to its
recruitment to transcription sites. Biochemical characterization of the IGC
proteome has identified several subunits of RNA pol II (132; N. Saitoh, P.
Figure 5 Cartoon of a mammalian cell nucleus showing the large number of nuclear
domains that have been identified. Those involved in aspects of transcription or associated
with transcription factors are discussed in the text.
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Sacco-Bubulya & D.L. Spector, in preparation), supporting the localization of at
least a population of RNA pol II in these nuclear domains.
The Cdk9-cyclin T complex, also known as TAK/P-TEFb, is thought to be
involved in transcriptional elongation via phosphorylation of the RNA pol II LS
[reviewed in (133)]. This complex was found diffusely distributed throughout the
nucleoplasm, with the exception of the nucleoli (134). In addition, a significant
overlap between cyclin T1 and nuclear speckles was observed. A region in the
central portion of the cyclin T1 protein was found to be important for this
subnuclear targeting (134). However, Cdk9 was present in the vicinity of nuclear
speckles but a direct overlap was limited (134). Surprisingly, Cdk9 and cyclin T1
also showed only a limited colocalization with RNA pol II at sites on polytene
chromosomes in Drosophila (135). This lack of colocalization has been sug-
gested to possibly be due to a dynamic and short-lived interaction of these
proteins at transcription sites in vivo (135). Other members of the Cdk family,
Cdk7 and Cdk8, which are involved in transcriptional regulation, are not found
in nuclear speckles (136). Cdk7 was localized to Cajal bodies (Figure 5) in
addition to being diffusely distributed throughout the nucleoplasm (136).
FBI-1 is a cellular POZ-domain-containing protein that binds to the HIV-1
LTR and associates with the HIV-1 transactivator protein Tat (137). FBI-1 has
been found to partially colocalize with Tat and its cellular cofactor, P-TEFb, at
nuclear speckles (138). In addition, a less soluble population of FBI-1 is
distributed in a peripheral-speckle pattern that is dependent upon the FBI-1 DNA
binding domain and active transcription (138). This distribution may be associ-
ated with active transcription sites (perichromatin fibrils) that are found on the
periphery of IGCs (139, 140). The nucleosome binding protein HMG-17, which
can alter the structure of chromatin and enhance transcription, has been localized
in a pattern similar to that of FBI-1 (141).
OPT DOMAIN In addition to its diffuse distribution, in 30% of the HeLa cells
examined, Oct1 occurs in a highly localized domain often located close to a
nucleolus and measuring 1.0–1.5 m in diameter (117). However, in normal
human skin fibroblasts, Oct1 was found in four to six nuclear domains smaller
than those observed in HeLa cells. Based upon the localization of Oct 1, PTF
[PSE binding transcription factor, also known as SNAPc (snRNA-activating
protein complex)], a complex involved in activating transcription of snRNA
genes [reviewed in (142)], and the finding that transcription could be detected
within this nuclear domain, the region was named the OPT domain (Figure 5)
(116). RNA pol II as well as TBP (TATA binding protein) and Sp1 were also
found within the OPT domain (116). These domains were found to contain
transcripts generated by both RNA pol II and pol III (116). OPT domains
assemble during G1 and disappear early in S-phase (116), and they coincide with
a nuclear domain identified earlier as the polymorphic interphase karyosomal
association (PIKA) domain (143). Interestingly, OPT domains are often associ-
ated with chromosome 6p21 and chromosome 7, although they were not found
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associated with various Oct1- and PTF-dependent genes (i.e., U1 and U2
snRNAs, 7SK, hY RNA, histones) (116).
CAJAL BODIES Cajal bodies are nuclear organelles first identified as nucleolar
accessory bodies by Santiago Ramo´n y Cajal (144), and they are thought to
function in snRNP biogenesis (123). Populations of several transcription factors
including TFIIF and TFIIH have been localized to Cajal bodies in HeLa cells
(117). Cajal bodies are associated with histone genes as well as gene clusters
encoding the U1, U2, and U3 snRNAs (145, 146), although the organization of
genes in arrays is not necessary for Cajal body association, as several single-copy
snRNA loci also have a statistical preference to localize with Cajal bodies (147).
Interestingly, Matera and coworkers showed that artificial tandem arrays of U2
genes colocalized with Cajal bodies and the frequency of the colocalization was
directly dependent upon the transcriptional activity of the array. The association
was lost upon transcriptional inhibition or by promoter mutations (147). Impor-
tantly, the U2 coding region was required for the association, suggesting that the
association may be mediated through the snRNA nascent transcripts or a
polymerase complex (148). Interestingly, a recent study has shown these bodies
to associate with chromatin in the presence of transcription via an ATP-
dependent mechanism; upon ATP depletion the bodies exhibited increased
mobility that was described by anomalous diffusion (149).
PML BODIES PML nuclear bodies were first identified as nuclear domain 10
(ND10) by autoantibodies recognizing the Sp100 protein (150, 151). However,
interest in these bodies was significantly increased upon finding that a fusion
protein resulting from a t(15;17) translocation between the PML protein and the
retinoic acid receptor-, in acute promyelocytic leukemia, resulted in the dis-
ruption of these bodies (152–154). More interestingly, treatment of these indi-
viduals with retinoic acid or arsenic trioxide allowed them to go into remission
and concomitantly the PML bodies were reformed (152–154). A clear function
for these bodies has not yet been established, although roles in transcriptional
regulation, as storage sites regulating the levels of active proteins within the
nucleus or as sites of active proteolysis, have been pursued [reviewed in (124,
155–157)]. Earlier studies have reported transcription to occur in (158) or on the
periphery (159) of these bodies. In addition, the transcriptional coactivator
CREB-binding protein (CBP) has been localized to PML bodies in certain cell
types (Hep-2, SKN-SH, COS-1, and CHO) (160) and the coactivator p300 and
RNA polymerase II have been localized to a subset of PML bodies in some cell
types (Hep-2, HeLa, MCF-7, and T24) (158, 161). Of particular interest here is
the recent finding of a nonrandom association of the gene-rich MHC on
chromosome 6 with PML bodies (120). At least one homologue was associated
or overlapping with a PML body in 42% of the MRC-5 cells (normal human
fibroblasts) examined (120). This association was independent of active tran-
591DYNAMICS OF GENE REGULATION
A
nn
u.
 R
ev
. B
io
ch
em
. 2
00
3.
72
:5
73
-6
08
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
by
 C
ol
d 
Sp
rin
g 
H
ar
bo
r L
ab
or
at
or
y 
on
 1
2/
07
/1
2.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
scription. Interestingly, when several copies of a YAC containing a large
proportion of the MHC class II region was stably integrated into the long arm of
chromosome 18 in a B-lymphoblastoid cell line, monosomic for the short arm of
chromosome 6 and containing a large deletion of the MHC class II region, PML
bodies were found to be associated with the MHC class II YAC integration site
on chromosome 18, demonstrating the specificity of the association (120). The
localization of the transcription factor Sp100, which is involved in the constitu-
tive expression of several genes within the MHC region, to PML bodies has been
suggested to support a model in which PML bodies function in transcriptional
regulation, perhaps by regulating the soluble pool of transcription factors/
coactivators/corepressors (120). A recent study reexamining Br-UTP incorpora-
tion indicated that 9% of PML nuclear bodies were associated with
transcription sites and this association increased to 51% upon interferon-
treatment (162). As interferon treatment also increases the number of PML
bodies, the direct relationship of these bodies to transcription remains unclear.
Counter to an active role in transcription, a subset of PML bodies have been
shown to contain HP1 (163, 164), a protein associated with silenced chromatin
[reviewed in (165)]. In addition, the proteosome inhibitor MG132 induces a PML
body/centromere association in a significant number of cells in the G2 phase of
the cell cycle (163). Therefore, although it is unclear what role, if any, PML
bodies has in transcriptional regulation, their role(s) may be dynamic as cells
traverse the cell cycle, and/or different PML bodies within the same nucleus may
be involved in different activities. In this regard, a recent study has indicated that
a subset of these bodies exhibits ATP-dependent dynamics (166).
HSF1 GRANULES Upon activation of the mammalian heat shock transcription
factor 1 (HSF1) by stress, heat shock genes are turned on and HSF1 relocalizes
to nuclear bodies termed HSF1 granules (125) or stress-induced Src-activated
during mitosis nuclear bodies (SNBs) (126). Although numerous RNA binding
proteins have been localized to these granules, transcription does not occur
within these nuclear regions. Recently, the granules were shown to bind to a
nucleosome-containing subclass of satellite III repeats at the human 9q11-q12
pericentromeric heterochromatin region (125), as well as to the centromeric
regions of chromosomes 12 and 15 (126). It is unclear why these specific
chromosomal regions are the targets for HSF1 granules and what role these
granules have in nuclear metabolism.
POLYCOMB GROUP GRANULES Polycomb group (PcG) protein complexes local-
ize at specific sites in Drosophila called Polycomb response elements (PREs) and
in doing so repress genes in cis [reviewed in (167)]. Such elements have not yet
been identified in mammalian cells, although homologues of PcG genes have
been identified and they appear to function in silencing as do their Drosophila
counterparts. Interestingly, human polycomb group (PcG) complex proteins are
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localized in a fine granular distribution throughout the nucleoplasm and are also
localized to a varying number of larger domains ranging in size from 0.2 to 1.5
m in diameter; these domains have been termed PcG granules [reviewed in
(167, 168)]. These granules associate with pericentromeric heterochromatin
regions on human chromosome 1 (1q12) and with related sequences on other
chromosomes (167, 168), and the association is maintained throughout mitosis.
However, recently Fakan and co-workers have examined the localization of four
members (HPC2, HPH1, BMI1, and RING1) of the human PcG protein family
in two cell types and tissue sections by immunoelectron microscopy (169).
Although the BMI1 and HPC2 proteins localized to PcG granules, the four
proteins were found highly concentrated on the border of condensed chromatin
domains in perichromatin nuclear regions. In addition, the PcG proteins were
found in the interchromatin space, a region devoid of chromatin, although at a
five- to tenfold lower concentration (169). However, these proteins were nearly
absent from regions of condensed chromatin. Based on this localization, the
authors proposed that loci silenced by PcG proteins are spatially interspersed
among transcriptionally active genes (169). These findings argue against a model
in which silencing of genes by association with PcG proteins gives rise to the
repositioning of silenced loci inside compact chromatin domains. However, they
are in agreement with similar studies in Drosophila in which PcG proteins were
found to occupy different positions on polytene chromosomes than HP1, a
marker for constituitive heterochromatin (170, 171). Interestingly, several recent
studies have identified a role for the Extra Sex Combs (ESC) and Enhancer of
Zeste E(z) PcG protein complex in the trimethylation of lysine-9 and the
methylation of lysine-27 of histone H3 (172–174), resulting in the recruitment of
other Polycomb proteins to the histone H3 amino-terminal tail and mediated
silencing.
SEQUESTRATION IN THE CYTOPLASM A significant number of transcription
factors are localized in the cytoplasm and only upon activation by a signaling
molecule are they transported into the nucleus, where they bind DNA to activate
transcription [reviewed in (175, 176)]. Among such factors are members of a
broad array of transcription factor families including STATs (signal transducers
and activators of transcription), NF-Bs (nuclear factors of Ig B cells), NFATs
(nuclear factors of activated T cells), and the glucocorticoid receptor. Of this
class of factors, perhaps the best-studied at the cell biological level is the
glucocorticoid receptor (GR) (79, 107, 177). Hager and colleagues have utilized
a cell line containing a tandem array of200 copies of a mouse mammary tumor
virus promoter-driven ha-v-ras gene (178) to examine the dynamics of transcrip-
tion and the association of transcription factors with this endogenous template
(79, 107). After steroid hormone treatment, a GFP-GR fusion was shown to enter
the nuclei and associate with the arrays. The arrays decondensed within 3 h of
hormone treatment and then recondensed over the next 6 h (178).
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TRANSLATION IN THE NUCLEUS
The nuclear envelope was thought to functionally demarcate the nuclear com-
partment where transcription and RNA processing occurs from the cytoplasmic
compartment where translation occurs. However, a recent study indicated that a
low level of translation occurs within the nucleus (179). When biotin-lysyl-
tRNAlys or BODIPY-lysyl-tRNAlys were used to label newly made proteins in
vivo, using conditions where nascent polypeptides are extended by15 residues,
discrete sites were identified within nucleoli and the nucleoplasm in addition to
the prevalent cytoplasmic labeling (179). The nuclear signal represented 15% of
the total incorporation. A similar degree of labeling was observed in isolated
nuclei lacking 95% of the cytoplasmic ribosomes. Treatment with cyclohexi-
mide reduced the nuclear labeling to 4%, and an inhibition of nuclear import did
not affect incorporation. In support of these incorporation studies, immunofluo-
rescence analysis has shown that populations of a number of different translation
factors including eIF2, eIF3, eIF4, eIF4E as well as ribosomal proteins L7 and
QM were present in nuclei (179). A portion of the observed nuclear translation
was dependent upon concurrent transcription by RNA pol II, and immunogold
labeling at the electron microscopic level showed a colocalization of some
nascent RNA and nascent polypeptides (179). Based upon these data, the authors
suggested that nuclear translation may function in nonsense-mediated decay, a
quality control mechanism in which mRNAs are surveyed for the presence of
nonsense codons. Support for this possibility comes from studies showing that
nonsense mutations can affect pre-mRNA 3 end processing (180) and result in
an accumulation of pre-mRNAs at transcription sites (181). To determine
whether ribosomes are recruited to nascent transcripts, Brogna et al. (182) used
antibodies to 20 different ribosomal proteins and probes complementary to 18S
and 28S rRNA to demonstrate that the translation apparatus is present at
transcription sites on the giant polytene chromosomes of Drosophila melano-
gaster salivary glands. The presence of both 18S as well as 28S rRNA suggests
the presence of assembled ribosomes (182). Furthermore, these components were
concentrated at interbands and were particularly apparent at major puffs. The
kinetics of ribosomal protein recruitment to two different ecdysone-inducible loci
indicated that the association occurs cotranscriptionally and prior to the comple-
tion of pre-mRNA splicing (182).
GENE SILENCING AND NUCLEAR POSITIONING
Equally important to gene activation is gene silencing, a process by which the
inactivity of a gene or set of genes is important to the overall viability of the cell
and/or organism or to its differentiation. Two of the best-studied examples of
mammalian cell silencing relating to subnuclear positioning are the dosage
compensation achieved by X-chromosome inactivation in female mammals
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[reviewed in (183)] and the positioning of inactive genes adjacent to centromeric
heterochromatin [reviewed in (184)]. Here, I focus on the relationship of nuclear
organization to gene silencing; for an examination of changes in chromatin
structure and modifications relating to silencing the reader is referred to other
recent reviews (165, 185–187).
The Inactive X Chromosome
As discussed earlier, gene-rich chromosomes are generally located in more
internal nuclear regions, whereas gene-poor chromosomes are located in more
peripheral areas of the nucleus (34). However, one of the clearest examples of the
peripheral localization of a chromosome territory is provided by the inactive X
chromosome in female mammals (71, 188). The transcriptionally inactive X
chromosome consists largely of heterochromatic regions and forms a dense
nuclear domain, the Barr body, which is often found associated with the nuclear
periphery. X-chromosome inactivation results in the transcriptional silencing of
several thousand genes and ensures dosage compensation for X-linked gene
products between XX females and XY males (189). However, about 15% of the
genes on the human X chromosome escape X inactivation (190). X inactivation
is controlled by the X-inactivation center (Xic), which is essential for the
developmentally regulated initiation and spread of inactivation along the X
chromosome [reviewed in (183)]. A key player in the cis-acting function of the
Xic is the Xist gene. Xist produces a nuclear, untranslated RNA that is expressed
uniquely from the inactive X chromosome, coating it in cis (191, 192). In
addition, the noncoding antisense transcript Tsix represses Xist expression and is
thought to regulate X chromosome choice at the onset of inactivation (193, 194).
Other features associated with the inactive X chromosome are its late replication
timing, the methylation of CpG islands, the hypoacetylation of histones H3 and
H4 (195), methylation of H3 lysine-9 as well as hypoacetylation of H3 lysine-9
and hypomethylation of H3 lysine-4 (186, 196), and its enrichment in a histone
H2A variant, macro H2A.1 (197). Although these and other differences in the
shape, size, and surface properties of the inactive X chromosome have been
reported (198, 199), the mechanism behind its commonly observed peripheral
localization has not been elucidated.
Repositioning to Pericentric Heterochromatin
In a pair of now classic studies, Sedat and coworkers and Csink & Henikoff
demonstrated that the brown gene in Drosophila was silenced by contact with
centromeric heterochromatin (200, 201). The brown Dominant (bwD) allele, a null
mutation caused by the insertion of a block of heterochromatin within the coding
sequences of the brown gene, causes the bwD gene to be misdirected and to
associate with centromeric heterochromatin. Most interestingly, in bw/bwD
larva, as a consequence of homologous chromosome pairing, the wild-type allele
also localized to the centromere, providing an explanation for the variegated
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inactivation of the normal bw gene (200). Subsequently, this association of
silenced genes with centromeric heterochromatin was found to also occur
naturally in other cell types. In cycling but not quiescent B cells, transcriptionally
active genes are generally positioned away from centromeric heterochromatin,
whereas many inactive genes are localized adjacent to heterochromatin domains.
For example, the expressed alleles of the IgH and Ig immunoglobulin heavy and
light chain genes in lymphocytes occupy nuclear positions away from hetero-
chromatin as opposed to their heterochromatin-associated nonexpressed alleles
(202). A similar situation occurs in developing immature thymocytes, where the
Rag-1 and TdT genes are downregulated and upon transcriptional termination the
genes are repositioned to centromeric regions (203). As the observed reposition-
ing occurs after transcriptional shutdown, locus movement appears to be a result,
rather than a cause, of shutdown (203). This repositioning is heritable and stably
transmitted through cell division (203). The heritable silencing of genes has also
been found in T lymphocytes where CD4 T cells can be induced to develop into
Th1 or Th2 cells (T-helper subsets). In this case, the IL-4 (in Th1) and
–interferon genes (in Th2) are positioned near centromeric domains (204).
Based upon these studies, Fisher and co-workers have proposed a model in which
an active target gene localized in a transcriptionally permissive environment is
sequestered, upon transcriptional shut-down, to a repressive environment by a
hypothetical “recruiter” (205). The recruitment is proposed to be initiated by
increased binding of factors to motifs in the target genes, or alternatively,
centromere-bound recruiters may access and interact with target genes when
motifs previously occupied by transcriptional activators are vacated (205). Of
particular interest has been the search for proteins that might mediate the
repositioning and/or silencing of these genes. An interesting candidate with
regard to the lymphoid lineage is the Ikaros protein. Ikaros is required for normal
hemopoiesis, and it shares homology with the Hunchback protein in Drosophila
(206, 207), which has been implicated in Polycomb recruitment and the estab-
lishment of silencing complexes in Drosophila (208, 209). Interestingly, Ikaros
has been shown to interact with chromatin remodeling proteins, to colocalize
with many inactive genes in lymphocyte nuclei, and to bind to lymphoid-specific
promoter sequences as well as to centromere-associated repetitive DNA
[reviewed in (184)]. These characteristics are consistent with either a direct role
for the Ikaros protein in transcriptional repression or a role as a mediator of silent
chromatin. Ikaros is expressed at very low levels and localizes predominantly
within the cytoplasm of noncycling B lymphocytes (203). However, following
mitogenic activation, Ikaros levels increase and at about 3 days after stimulation
Ikaros is highly localized to centromeric clusters, as are transcriptionally
repressed genes (203). Smale and co-workers (210) have found that Ikaros
proteins compete with the ELF-1 activator for binding to the D region of the TdT
promoter, resulting in TdT downregulation in T-cell lines. Similar findings have
been made for a role of the Ikaros protein in silencing the 5 promoter of
transgenes in mature B cells (211).
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In an interesting extension of these studies, Francastel et al. (212) assessed the
ability of the -globin 5HS2 enhancer to influence silencing and nuclear
location of a transgene in mammalian cells. At genomic integration sites where
stable expression does not require the presence of an enhancer, transgenes
localized away from centromeric heterochromatin regardless of their transcrip-
tional activity. However, at sites where stable expression requires an intact
enhancer, active transgenes localized away from centromeric heterochromatin
when linked to a functional enhancer (212). Enhancer mutations that impair the
ability of the enhancer to suppress silencing also resulted in the transgene
remaining close to centromeric heterochromatin, even before the transgene was
silenced. Therefore, the same enhancer motifs are required for both suppression
of transgene silencing and localization of the transgene away from centromeric
heterochromatin (212). Based upon these data, functional enhancers were pro-
posed to antagonize gene silencing by preventing the localization of a gene near
centromeric heterochromatin or by recruiting a gene to a nuclear region that is
transcriptionally favorable and stably heritable (212). However, changes in
chromatin structure are likely also to be involved in gene positioning as
localization of the human -globin locus away from heterochromatin in mouse
erythroleukemia cells correlates with hyperacetylation in the promoter region,
even in the absence of transcription (213).
To further assess the interplay between gene silencing and transcriptional
activation in heterochromatic nuclear regions, Dillon and co-workers targeted a
pre-B-cell specific 5 transgene directly into pericentric heterochromatin in mice
(214). The integration resulted in strongly variegated expression in pre-B cells.
Analysis of the stability of the expression patterns indicated that the 5 transgene
undergoes a reversible switching between the active and repressed states,
resembling the telomeric silencing observed in S. cerevisiae (215). In both
expressing and nonexpressing clones, the transgene remained closely associated
with the periphery of the centromeric complex, indicating that activation of the
5 transgene does not require movement away from the heterochromatic region
(214). In fibroblasts, a DNase I hypersensitive site (HS1) was shown to be
responsible for locating the transgene to the outside of the pericentric hetero-
chromatin complex in the absence of transcription. Deletion of the HS1 site
resulted in the 5 transgene being embedded within the pericentric heterochro-
matin, demonstrating that changes in chromatin structure are directly involved in
genome organization (214). However, in pre-B cells, location of the transgene to
the outside of the heterochromatin complex was not linked to the HS1 site but
instead was related to the dosage of early B cell factor (EBF), as was the ability
of the transgene to be transcriptionally activated (214). Therefore, the level of
EBF affects both the higher-order chromatin structure and the transcriptional
activity of the heterochromatic 5 transgene. Importantly, relocation of this gene
away from heterochromatin was not required for transcriptional activation, and
transcription of this heterochromatin-associated gene was maintained through
multiple cell divisions. This study clearly demonstrated that gene regulation is a
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balance between factor levels/accessibility and chromatin condensation state
(214).
Interestingly, just as active genes can be juxtaposed to heterochromatin,
inactivation of transcription does not always occur through an association with
heterochromatin. In a study examining the expression and nuclear positioning of
the - and -globin genes in hemopoietic cells, Brown et al. identified differ-
ences in how the nuclear position of these two loci corresponds to their
transcriptional activity (216). In primary erythroblasts where both the human -
and -globin loci are active, they were both positioned away from centromeric
heterochromatin (216). In human primary T lymphocytes and immortalized B
cells, where these genes are not expressed, the -globin alleles were localized in
close proximity to centromeric DNA, although the -globin locus did not localize
close to centromeric DNA in cycling lymphocytes where these genes are
inactive. Even when integrated into different chromosomal sites, the -globin
genes neither remained discrete from centromeric heterochromatin, nor did they
localize with other regions of heterochromatin as demarcated by the localization
of HP1 (216). As the -globin locus exhibits characteristics generally attributed
to ubiquitously expressed genes, such as a lack of methylation, early replication
timing, and DNAse I sensitivity in all tissues, these attributes may influence the
chromatin associations and nuclear position of this locus within the nucleus
(216). However, in mammalian cells there is no genetic evidence that nuclear
position affects the repressed state, and it is not clear whether position is a result
or a cause of repression.
Telomeres and the Nuclear Periphery
In the yeast S. cerevisiae, telomeres as well as proteins associated with repressed
chromatin (Sir3 and Sir4) have been localized in clusters adjacent to the nuclear
envelope [reviewed in (217)]. A fascinating study of chromatin domains in live
yeast cells by Gasser and colleagues has shown that telomeres are highly
dynamic and move rapidly along the inner nuclear membrane in G1 and S phase
cells (83, 218). To test whether genes artificially drawn to the yeast nuclear
envelope could become transcriptionally silenced, a prior study by Sternglantz
and co-workers had shown that a HMR locus with a defective silencer can be
silenced by anchoring the locus to the nuclear envelope via the fusion of an
integral membrane protein to the GAL4 DNA binding domain (219). As the
concentration of Sir proteins is greater at the yeast nuclear periphery, silencing
was thought to be favored by artificially placing the locus in a nuclear environ-
ment that would be more favorable to silencing. However, since telomeres have
been shown to remain peripherally anchored in the absence of Sir proteins, other
factors are likely to play a role in this process (220, 221). In this regard, several
groups have reported that the Ku heterodimer is bound to telomeres and 50%
of the telomeres are displaced from the nuclear periphery in ku-deficient strains,
leading to a reduction in the repression of telomeres as well as silent mating-type
(HM) genes (222). As was found for the Sir proteins, anchoring and repression
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can occur, in certain cases, in the absence of Ku and therefore there is more to
the story. Recently, Feuerbach et al. have found that upon disruption of myosin-
like protein 2 (Mlp2p), a Ku-binding factor associated with the nuclear periphery,
a 20% increase in the number of telomeric foci was observed, suggesting
telomere dispersion (223). Furthermore, these authors have shown that a mem-
brane-anchored reporter to a subtelomeric region or to the silent mating-type
locus is sensitive to mutations in Mlps and the nuclear pore protein Nup60. In
contrast, repression of natural mating-type loci, which are also associated with
peripheral telomeric foci, is not affected by mutations in either Mlps or nuclear
pore proteins. Therefore, although it is clear that the peripheral localization of
telomeres in yeast coincides with transcriptional repression, multiple mecha-
nisms may be in play to regulate the association of telomeres with the nuclear
periphery (218).
The Nuclear Periphery and Gene Activity
Although strong connections exist between the nuclear periphery and silencing,
recently a genetic screen in S. cerevisiae to identify chromatin boundary activ-
ities (BAs) has identified a class of BAs that mediate their epigenetic function by
specific physical tethering to the NPC (224). Among the BAs identified were the
exportins Cse1p, Mex67p, and Los1p. These transport proteins were shown to
block spreading of heterochromatin by physical tethering of the S. cerevisiae
silent mating-type locus HML/boundary trap reporter ADE2 to the Nup2p
receptor of the NPC, the major docking site for the exportins on the NPC basket
(224). Genetic deletion of Nup2p abolished the BA of the transport proteins
directly implicating the NPC in chromatin regulation. Based upon these findings,
the authors posit that transportins block the propagation of heterochromatin by
tethering of the cis-acting boundary elements to the Nup2p receptor of the NPC
basket, thereby initiating a series of chromatin remodeling events (224).
Although this reporter assay provides an interesting scenario, it remains to be
determined whether genomic loci physically interact in a similar way with the
NPC.
REESTABLISHING THE GENE EXPRESSION
MACHINERY AFTER MITOSIS
In higher eukaryotes, mitosis is accompanied by dramatic transformations in the
structural organization of both the cytoplasm and nucleus. The onset of mitosis
is accompanied by chromatin condensation, breakdown of the nuclear envelope
(225), and cessation of bulk cellular transcription (226–228). The constituents of
many nuclear domains, such as nuclear speckles and other nuclear bodies,
become diffusely distributed throughout the cytoplasm (89, 229–231). However,
the gene expression machinery must be rapidly reactivated when cells exit from
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mitosis. A problem confronted by the mitotic cell is the establishment of the gene
expression machinery in daughter nuclei so that these cells become competent to
undergo transcription/RNA processing immediately as they exit from mitosis. A
recent study has investigated whether components of the gene expression
machinery enter postmitotic nuclei individually or as a unitary complex (232).
Interestingly, localization studies of numerous RNA pol II transcription and
pre-mRNA processing factors revealed a nonrandom and sequential entry of
these factors into daughter nuclei after nuclear envelope/lamina formation (Fig-
ure 6). The initiation-competent form of RNA pol II and general transcription
factors appeared in the daughter nuclei simultaneously, but prior to premRNA
processing factors, whereas the elongation competent form of RNA pol II was
detected even later (232). The differential entry of these factors rules out the
possibility that they are transported as a unitary complex. Furthermore, the
differential entry is unlikely to be due to a nuclear retention mechanism based
upon substrate binding, as previous studies have shown that pre-mRNA splicing
factors (229) as well as RNA pol II (K.V. Prasanth and D.L. Spector, unpublished
data not shown) enter daughter nuclei and are maintained in the absence of RNA
pol II transcription. Although the mechanism that regulates the sequential
recruitment has not been elucidated, it may involve the activation of different
importin- family members. Telophase nuclei were competent for transcription
and pre-mRNA splicing concomitant with the initial entry of the respective
factors. In addition, a low turnover rate of transcription and pre-mRNA splicing
factors was found during mitosis, demonstrating that these factors were recycled
Figure 6 Schematic representation of the order of recruitment of the gene expression
machinery into daughter nuclei at the end of mitosis (232).
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into daughter nuclei as the cells progress through telophase (232). Based upon
these data, the authors present a model in which the entry of the RNA pol II gene
expression machinery into newly forming daughter nuclei is a staged and ordered
process (232). This ordered entry of transcription factors prior to pre-mRNA
splicing factors appears to be a general phenomenon as similar results were
observed in transformed cells (HeLa) as well as in cells of defined passage
number (IMR90). The observed sequential recruitment of proteins into daughter
nuclei may establish favorable cues for transcription initiation within the context
of the decondensing chromosomes.
PERSPECTIVES
Progress in the field of chromosome organization and gene regulation has been
substantial over the past few years. The ability to visualize individual chromo-
some territories within the cell has allowed an investigation of the organization
of chromosomes within the three-dimensional structure of the cell nucleus. Such
studies have indicated that while there is probably not a functionally obligate
position for each chromosome within the nucleus, gene complexity and/or
chromosome size may influence chromosome position. The overall organization
of individual chromosome territories is such that active genes are located
throughout the territory and are not restricted to the periphery, as initially posited.
In fact, in some cases, large chromosomal loops containing active genes extend
outside of the respective chromosome territories (52, 58, 59). This finding raises
concern regarding the interpretation of interphase chromosome paint studies. Based
upon our current rate of advancement, it is not unrealistic to anticipate studies that
will examine the organization of clusters of adjacent genes within the same chro-
mosome territory in living cells, providing higher-resolution insight into the three-
dimensional organization of the genome. Are genes repositioned upon their
inactivation? Numerous studies have indicated the movement of inactive genes to
centromeres, resulting in heritable silencing. However, association with centromeres
or the nuclear periphery in mammalian cells in and of itself does not appear sufficient
to result in silencing. Increased telomeric repression in yeast has been correlated with
anchoring, and silent chromatin was shown to be tethered to the nuclear envelope in
a Sir-dependent manner during S-phase (218).
Whereas chromosome territories generally remain in their nuclear neighbor-
hood, particular genes or gene clusters appear to be dynamic and can move via
constrained Brownian motion. However, overall movements seem to follow a
random walk as no directed movements have been observed (73, 82). In some
cases, such movements seem to correlate with entry into S-phase or transcrip-
tional activation. Chromosome constraint may be imparted through centromeres
and telomeres and/or associations with the nucleolus and nuclear envelope/
lamina. The technology is currently in place for future studies to examine these
associations directly in living cells through the cell cycle, and we can expect
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significant insight over the next few years. Surprisingly, diffusion is not the only
means of chromatin movement. A recent elegant study in yeast indicated that
ATP-dependent movements of chromosomal regions also occur (83). It will be
important to determine how widespread such movements are and whether they
occur in other cell systems containing different levels of heterochromatin.
RNA polymerase II transcription has been reported to occur at nearly 8000
sites scattered throughout the nucleoplasm (95). Contrary to earlier indications,
chromosome territories are accessible to RNA polymerase and transcription
factors that are freely diffusing throughout the nuclear space (56). Intriguingly,
transcription factors studied to date show rapid exchange rates at transcription
sites, with residency times ranging from seconds to minutes, supporting a
“hit-and-run” model (107). Various transcription factors are also localized to
different nuclear bodies. Although many of these bodies are preferentially
associated with specific chromosomal regions, we await future studies to deter-
mine the functional relevance of these associations. Given our current ability to
visualize genetic loci and factors in living cells, we are on the verge of being able
to perform in-depth studies of gene expression with the ability to simultaneously
visualize DNA, RNA, and protein in real time. In summary, while there have
been many advances in our understanding of the organization and dynamics of
the genome and its regulatory factors, one point that stands out is the balance
between organization and a degree of plasticity, which may represent an inherent
mechanism to ensure proper gene expression.
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